| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/31/2002 | WO2002008209A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 01/31/2002 | WO2002008197A1 Biphenyl carboxamides |
| 01/31/2002 | WO2002008195A1 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
| 01/31/2002 | WO2002008191A1 Potassium channel inhibitors |
| 01/31/2002 | WO2002008190A2 Novel heteroaryl derivatives and use thereof as anti-tumour agents |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | WO2002008183A2 Potassium channel inhibitors |
| 01/31/2002 | WO2002007730A1 Alpha v integrin receptor antagonists |
| 01/31/2002 | WO2002007683A1 Antimicotic nail varnish composition |
| 01/31/2002 | WO2002007673A2 Calcilytic compounds |
| 01/31/2002 | WO2001070668A3 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 01/31/2002 | WO2001007497B1 Performance of energy storage devices: potential areas for dendritic chemistry involvement |
| 01/31/2002 | US20020013465 Reacting a benzamidine compound with a amide substituted pyrazole compound |
| 01/31/2002 | US20020013464 Reacting a benzamidine compound with a amide substituted pyrazole compound |
| 01/31/2002 | US20020013431 Oligomerization of ethylene |
| 01/31/2002 | US20020013357 Valdecoxib compositions |
| 01/31/2002 | US20020013354 p38 map kinase inhibitors |
| 01/31/2002 | US20020013352 Novel substituted diamine derivatives useful as motilin antagonists |
| 01/31/2002 | US20020013351 Compounds possessing neuronal activity |
| 01/31/2002 | US20020013349 Administering drug which opens potassium channel for reducing pain |
| 01/31/2002 | US20020013306 Terpyridine-platinum(ii) complexes |
| 01/31/2002 | US20020013296 Treating with agonists at kappa opioid receptors such as methyl-4-(2-glycyl-4-(trifluoromethylphenyl)acetyl)-3-(R,S)-((1 -pyrrolidinyl)-methyl)-1-piperazinecarboxylate |
| 01/31/2002 | DE10034803A1 Substituierte Sulfonsäureanilide Substituted Sulfonsäureanilide |
| 01/31/2002 | CA2417462A1 Programmable molecular device |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2416870A1 Potassium channel inhibitors |
| 01/31/2002 | CA2416865A1 Potassium channel inhibitors |
| 01/31/2002 | CA2416751A1 Alpha v integrin receptor antagonists |
| 01/31/2002 | CA2416537A1 Calcilytic compounds |
| 01/31/2002 | CA2415606A1 Capsaicin receptor ligands |
| 01/30/2002 | EP1176618A1 Metal complex dye, photoelectric conversion device and photoelectric cell |
| 01/30/2002 | EP1176184A2 Mesomorphic compound, polymeric mesomorphic compound, and electrolyte and secondary battery including same |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP1176134A1 Ligands of nuclear receptors ppar's |
| 01/30/2002 | EP1175416A1 Heteroaryl diazacycloalkanes, their preparation and use |
| 01/30/2002 | EP1175385A1 D-mannitol derivatives as hiv aspartyl protease inhibitors |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP0944600B1 Process for converting hydroxy heteroaromatics to arylamines |
| 01/30/2002 | EP0937044B1 Cftr channel activator compounds and pharmaceutical compositions containing same |
| 01/30/2002 | EP0907634B1 Pesticides |
| 01/30/2002 | EP0766673B1 Substituted oxime derivatives useful as pde iv inhibitors |
| 01/30/2002 | EP0724571B1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333765A Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 01/30/2002 | CN1333751A Substituted pyridine Herbicides |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/30/2002 | CN1333747A ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
| 01/30/2002 | CN1332962A Process for prepairng weedicide imidazolinone compound |
| 01/30/2002 | CN1078586C Phenylalkanamide derivatives and agrohor-ticultural bactericides |
| 01/29/2002 | US6342633 O-benzyl oxime ether derivatives and their use as pesticides |
| 01/29/2002 | US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating |
| 01/29/2002 | US6342599 1,3,4-oxadiazine derivatives and their use as pesticides |
| 01/29/2002 | US6342512 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | US6342504 Peptides as antithrombins and anticoagulants |
| 01/29/2002 | US6342503 Antidepressants, eating disorders |
| 01/29/2002 | US6342500 Antidiabetic agents |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/29/2002 | CA2165996C Stereoselective preparation of 2-substituted succinic derivatives |
| 01/24/2002 | WO2002006276A1 Beta3 adrenergic agonists |
| 01/24/2002 | WO2002006244A1 Heterocyclic substituted herbicidal sulphonic acid anilides |
| 01/24/2002 | WO2002006236A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 01/24/2002 | WO2002006235A1 Heterocyclic beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006234A1 Sulfone derivatives, process for their production and use thereof |
| 01/24/2002 | WO2002006215A1 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 01/24/2002 | WO2002005819A1 Compounds and methods |
| 01/24/2002 | WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | WO2002005801A2 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 01/24/2002 | WO2002005798A2 Pharmaceutical compositions for treating neurological disorders |
| 01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 01/24/2002 | WO2000071107A8 New pharmaceutical combinations for nos inhibitors |
| 01/24/2002 | US20020010338 Phenyl-keto-imidazolidine thioamide derivatives |
| 01/24/2002 | US20020010337 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 01/24/2002 | US20020010185 Anticarcinogenic agents |
| 01/24/2002 | US20020010158 Derivatives of 5-pyridylalkylphosphonates and 5-pyridylalkylmalonates useful drugs for treatment of cardiovascular related diseases and diabetes mellitus related diseases |
| 01/24/2002 | US20020010120 Composition and method for bleaching a substrate |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | US20020009635 Novel materials for use as electrolytic solutes |
| 01/24/2002 | US20020007522 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 01/24/2002 | US20020007521 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 01/24/2002 | CA2416384A1 Sulfone derivatives, their production and use |
| 01/24/2002 | CA2415906A1 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 01/24/2002 | CA2415901A1 Pharmaceutical compositions and methods for use |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/24/2002 | CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/23/2002 | EP1174427A1 Method for pulvirizing to fine powder |
| 01/23/2002 | EP1174150A1 Preventives/remedies for angiostenosis |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173411A1 Polyaldimines of oligomeric aminobenzoic acid derivatives, and their use for preparation of moisture-curable, storage-stable, one-part polyreas |
| 01/23/2002 | EP1173180A1 Camptothecin analogs and methods of preparation thereof |
| 01/23/2002 | EP1173161A2 Glucamine compounds for treating hepatitis virus infections |
| 01/23/2002 | EP0904269B1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 01/23/2002 | EP0888291B1 New process for preparing pesticidal intermediates |
| 01/23/2002 | CN1332734A Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity |